OpenBilldrug price receipt

NADAC week of 2026-10-14

IMVEXXY 4 MCG STARTER PACK

For 1 unit (EA)

Pharmacies pay

$27.11 filed

1 × $27.10903 per EA

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-06-01 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D paid

$25.69 filed

1 × $25.69428 per EA, Part D average

Medicare's price is not your price.

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18


The spread

0.95× estimated

Medicare paid 5% less than pharmacies pay.

Part D averages every strength and form sold under “Imvexxy” / “Estradiol” into one figure, so it is not specific to this NDC.

OpenBill calculation · DSD_PTD_RY26_P04_V10_DY24_BGM.csv + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-06-01 (file of 2026-10-14, retrieved 2026-10-17) · Part D 2024-01-01 to 2024-12-31 (file of 2026-06-25, retrieved 2026-10-18)

Cost-plus estimate

$36.18 estimated

$27.11 + $4.07 (15%) + $5.00 fee per fill = $36.18

This is a model, not a price any pharmacy quoted. Shipping is not included. How it is worked out

OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-06-01 (file of 2026-10-14, retrieved 2026-10-17)

Open the interactive card Change the quantity, type what you were charged, and see every record in full.

What it is

IMVEXXY 4 MCG STARTER PACK is how the CMS NADAC file names this product. The FDA NDC Directory does not list its NDC as a package of its own, so OpenBill has no FDA names, dosage form or pharmacologic class for it.

The NADAC file of 2026-10-14 prices it under one NDC (National Drug Code), 68308-0747-18.

NADAC classes it as a brand-name drug (rate-setting class B), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $27.11 for 1 unit (EA) (1 × $27.10903 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-06-01. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation code for it: 4, carried forward from the previous file.

This NDC’s NADAC was carried forward from an earlier file (NADAC explanation code 2 or 4), not newly surveyed: it took effect on 2026-06-01. The file is new; the price is not.

The NDC

What Medicare paid

Medicare Part D paid $25.69 for 1 unit (EA), at an average of $25.69428 per EA in 2024 (2024-01-01 to 2024-12-31) for “Imvexxy” and “Estradiol”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).

That average covers 34,317 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.

Medicare's price is not your price.

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.

Questions

Why is the comparison with Medicare for IMVEXXY 4 MCG STARTER PACK labelled estimated?
Beyond what the card shows, the records give these reasons: The Part D figure covers 2024-01-01 to 2024-12-31; the NADAC price is from the file of 2026-10-14. Part D spending basis, as the Part D record states it: Part D 2024 average spend per dosage unit for Imvexxy / Estradiol: all makers, strengths, forms and routes combined, claim-weighted; gross cost incl. dispensing fees and patient pay, before rebates. Unit taken as NADAC's EA. Joined on brand name.
Why does this page start at 1 unit (EA)?
NADAC prices this product per EA. The FDA NDC Directory does not list its NDC, and its NADAC name (“IMVEXXY 4 MCG STARTER PACK”) does not say whether it is an oral tablet or capsule, so the card starts at 1 rather than guess a month’s supply; change it to match your prescription.